Abstract
The recent amendment process of EU legislation on GMOs allows Member States to restrict or prohibit the cultivation of GMOs on their territory for reasons others than health or environment protection. The amending Directive 2015/ 412 is presented as a means to overcome the deadlock in GMO decision making. However, one may raise doubts on whether new article 26b of Directive 2001/ 18/ EC may provide for an adequate solution, since measures adopted on its ground are likely to be in non-compliance with EU or WTO law. Moreover, the amending directive remains in line with the previous legislative framework, as far as is concerned on the one hand, the disregard for scientific uncertainty and disagreement and, on the other hand, the artificial distinction between risk assessment and risk management, failing to promote more comprehensive and democratic scientific opinions and political decisions.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
